Orchestra BioMed Holdings, Inc.
OBIONASDAQ
Healthcare
Biotechnology
$4.26
-0.08(-1.8%)
52W $2.35 – $5.35
Quick:
10-K
Mar 12, 2026 (3 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 27, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Feb 25, 2026 (1 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Feb 13, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Nov 19, 2025 (4 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 10, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 30, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 28, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 12, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13D/A
Aug 6, 2025 (8 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Aug 4, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 31, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 24, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 12, 2025 (10 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13D/A
May 1, 2025 (11 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Apr 29, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Apr 29, 2025 (11 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active